Loading
A hospital in Ariana, north of Tunis, with a radiotherapy unit of two linear accelerators. It is a site for an international breast cancer trial.
IAEA DIRAC's equipment report, read on 11 November 2026 with the entry updated in 2026, lists the hospital's radiotherapy unit in Ariana with two linear accelerators and a CT scanner, and no brachytherapy. ClinicalTrials.gov lists Abderrahmen Mami Hospital, Aryanah, as a site of the trial of inavolisib with pertuzumab and trastuzumab in PIK3CA-mutated HER2-positive breast cancer (NCT05894239). OnCo found no website for the hospital.
Shares A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer, Institut Salah Azaïez, Breast cancer (all types).
Shares A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer, Institut Salah Azaïez, Breast cancer (all types).
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/